LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC
Delisted
LOGC was delisted on the 15th of November, 2022.
37 hedge funds and large institutions have $165M invested in LogicBio Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
37
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$5.07M | |
| 2 | +$1.11M | |
| 3 | +$669K | |
| 4 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
+$523K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$381K |
Top Sellers
| 1 | -$4.13M | |
| 2 | -$1.23M | |
| 3 | -$343K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$46.9K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$9.69K |